http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-144065-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6042509de7544921c96de43b9da1438 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 |
| filingDate | 2007-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1dbe0f211594826aa5fa19af6ab4be01 |
| publicationDate | 2008-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SG-144065-A1 |
| titleOfInvention | Oral contraceptive spray |
| abstract | ORAL CONTRACEPTIVE SPRAY The subject invention provides a liquid contraceptive formulation for oral transmucosal administration. The formulation comprises etonogestrel, optionally together with ethinyl estradiol but does not contain a matrix former or a percutaneous absorption promoter, which is a hydroxyl acid or a salt thereof. |
| priorityDate | 2006-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.